• Accueil >
  • Publications >
  • COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients

COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients

1 mars 2018Anticancer Research

DOI : 10.21873/anticanres.12375